Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Kenvue Inc. Common Stock (KVUE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Kenvue Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.9 (market cap $4.59B), while Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B). The key difference: Kenvue Inc. Common Stock is far larger — about 7.4× Definium Therapeutics Inc. Common Shares's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals.
| DFTX | KVUE | |
|---|---|---|
Market Cap | $4.59B | $34.06B |
Volume | 2,103,937 | 23,267,228 |
Sector | Health | Consumer Staples |
52-Week High | $48.45 | $19.83 |
52-Week Low | $10.68 | $14.11 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $3.55B | $41.56B |
Dividend Yield | — | 4.74% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →
